The Critical Edge Podcast

Welcome to The Critical Edge, the podcast where cutting-edge trauma surgery and critical care research meets clear, actionable insight—curated by a Harvard-trained, AAST-certified trauma surgeon dual-boarded in Surgical Critical Care and General Surgery.In each episode, we distill the latest high-impact studies, meta-analyses, and guideline updates—from journals like the Journal of Trauma and Acute Care Surgery, Journal of the American College of Surgeons, World Journal of Surgery, and EAST Practice Management Guidelines—into digestible discussions. Whether it’s evolving damage control resuscitation strategies, refined whole blood protocols, updated ERATIC (Enhanced Recovery After Trauma and Intensive Care) recommendations, geriatric trauma management, or debates around REBOA and non-operative approaches to solid organ injuries, we break it down with clinical relevance front and center.No fluff, no filler—just the evidence that matters right now in the OR, ICU, or trauma bay. Perfect

The Critical Edge Podcast is a health podcast hosted by The Critical Edge, with 50 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

The Critical Edge hosts The Critical Edge Podcast, a health show with 50 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #66

  2026 Comprehensive General Surgery-Part 2

  Sep 7, 20261h 6m

  This episode offers a comprehensive look at modern surgical interventions and clinical management protocols for a wide array of medical conditions. Several studies focus on gastrointestinal issues, ranging from the endoscopic treatment of esophageal varices and foreign body removal to the surgical correction of rectal prolapse. Emergency and trauma-related care are also heavily featured, with guidelines detailing how to handle blunt cerebrovascular injuries, thoracic aortic damage, and the timing of tracheostomies for spinal cord injuries. Additionally, the sources explore specialized diagnostic challenges, such as identifying biliary hyperkinesia and assessing cancer risks during appendectomies. Other critical topics include the management of ectopic pregnancies and the multidisciplinary approach required to treat chylothorax. Together, these texts serve as an essential resource for understanding evidence-based practices in contemporary surgical and acute care. DISCLAIMER The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns. CLINICAL PERSPECTIVES IN SURGICAL AND GASTROINTESTINAL CARE: STUDY GUIDE TOP TEN TAKEAWAYS Endoscopic Management of Varices: Endoscopic treatment remains a primary clinical intervention for esophageal varices, focusing on stabilization and mitigation of gastrointestinal bleeding. Biliary Hyperkinesia Definition: Biliary hyperkinesia is a recognized gallbladder pathology; recent research has sought to define its characteristics and evaluate the effectiveness of cholecystectomy as a treatment. Thyroglossal Duct Cyst Identification: A distinguishing physical finding for a thyroglossal duct cyst is its characteristic ascension when the patient swallows. Ectopic Pregnancy as Lifesaving Care: Clinical management of ectopic pregnancy is categorized as essential, lifesaving medical care. BCVI Management Standardization: The Eastern Association for the Surgery of Trauma (EAST) provides specialized practice management guidelines for the evaluation and treatment of blunt cerebrovascular injury (BCVI). Optimizing Tracheostomy Timing: In the context of acute traumatic spinal cord injury (SCI), the timing of a tracheostomy procedure is a critical factor evaluated through systematic reviews and meta-analyses. BTAI Decision Algorithms: The Western Trauma Association (WTA) has established a critical decisions algorithm to guide the management of blunt thoracic aortic injury (BTAI). Chylothorax Multidisciplinary Approach: Successful management of chylothorax requires a multidisciplinary framework, integrating various clinical specialties to address the complex nature of the condition. Rectal Prolapse Clinical Standards: Guidelines for the treatment of rectal prolapse involve standardized clinical practices to improve patient outcomes and surgical efficacy. Appendiceal Cancer Risks: The increasing use of nonoperative management for appendicitis necessitates an understanding of the underlying risk of appendiceal cancer in patients presenting with appendicitis. -------------------------------------------------------------------------------- STUDY GUIDE This study guide synthesizes current clinical perspectives across gastrointestinal, trauma, and surgical specialties based on recent medical literature. I. Gastrointestinal and Hepatobiliary Interventions Endoscopic Treatment of Esophageal Varices The management of esophageal varices heavily relies on endoscopic techniques. These procedures are essential for patients at risk of or currently experiencing variceal hemorrhages. Clinical liver disease research emphasizes the role of these interventions in stabilizing patients and managing the complications of portal hypertension. Biliary Hyperkinesia and Cholecystectomy While biliary dyskinesia (low gallbladder ejection fraction) is well-known, biliary hyperkinesia represents a state of overactivity. Research focuses on defining this condition more clearly and determining if cholecystectomy (gallbladder removal) provides symptomatic relief for patients displaying hyperkinetic behavior on diagnostic imaging. Foreign Body Ingestion Endoscopy is also the standard for treating foreign body ingestion. Predictors of successful outcomes in these cases are identified through cross-sectional studies, which analyze the efficacy of endoscopic removal based on the type of object ingested and the patient's clinical presentation. II. Trauma and Vascular Care Guidelines Blunt Cerebrovascular Injury (BCVI) BCVI involves damage to the carotid or vertebral arteries resulting from blunt force trauma. Due to the high risk of stroke, the Eastern Association for the Surgery of Trauma (EAST) has developed specific practice management guidelines. These include rigorous evaluation protocols and standardized management strategies to prevent secondary neurological injuries. Blunt Thoracic Aortic Injury (BTAI) BTAI is a life-threatening condition requiring rapid decision-making. The Western Trauma Association (WTA) critical decisions algorithm provides a structured pathway for clinicians. This algorithm assists in determining the necessity of surgical repair versus medical management based on the severity and location of the aortic injury. Spinal Cord Injury (SCI) and Airway Management Patients with acute traumatic SCI often require long-term ventilation support. The timing of a tracheostomy—whether "early" or "late"—is a central theme in trauma care. Systematic reviews and meta-analyses seek to determine if earlier tracheostomy placement improves outcomes such as duration of mechanical ventilation and overall recovery. III. General and Specialized Surgical Considerations Thyroglossal Duct Cysts Typically observed in pediatric patients, a thyroglossal duct cyst is a midline neck mass. A definitive clinical diagnostic sign is the "ascension with swallowing," where the cyst moves upward as the patient deglutates, distinguishing it from other types of neck masses. Appendiceal Cancer and Nonoperative Management Recent shifts toward nonoperative management of appendicitis (using antibiotics instead of surgery) have raised concerns regarding missed diagnoses of appendiceal cancer. Studies indicate a measurable risk of cancer in patients undergoing appendectomy, suggesting that clinicians must weigh the benefits of avoiding surgery against the risk of underlying malignancy. Rectal Prolapse Clinical practice guidelines for rectal prolapse outline the current standards for surgical and supportive care. These guidelines help surgeons choose the most appropriate procedure to restore anatomy and improve the quality of life for affected patients. Chylothorax Chylothorax, the accumulation of chyle in the pleural space, is a complex condition that often follows thoracic surgery or trauma. Effective care involves a multidisciplinary management strategy that coordinates nutritional, medical, and surgical interventions. Ectopic Pregnancy Ectopic pregnancy management is recognized as a fundamental component of lifesaving care. Research in this area emphasizes the necessity of timely medical or surgical intervention to prevent maternal mortality and morbidity. -------------------------------------------------------------------------------- REFERENCES Zuckerman MJ, Elhanafi S, Mendoza Ladd A. Endoscopic treatment of esophageal varices. Clin Liver Dis. 2022;26(1):21-37. doi:10.1016/j.cld.2021.08.003 Kartik A, Jorge IA, Webb C, Lim ES, Chang YH, Madura J. Defining biliary hyperkinesia and the role of cholecystectomy. J Am Coll Surg. 2023;237(5):706-710. doi:10.1097/XCS.0000000000000793 Arredondo Montero J, Bronte Anaut M, Antona G, Pascual CB. Thyroglossal duct cyst: ascension with swallowing. J Pediatr. 2021;238:330-331. doi:10.1016/j.jpeds.2021.07.004 Bollig KJ, Friedlander H, Schust DJ. Ectopic pregnancy and lifesaving care. JAMA. 2023;329(23):2086-2087. doi:10.1001/jama.2023.7292 Kim DY, Biffl W, Bokhari F, et al. Evaluation and management of blunt cerebrovascular injury: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2020;88(6):875-887. doi:10.1097/TA.0000000000002668 Foran SJ, Taran S, Singh JM, Kutsogiannis DJ, McCredie V. Timing of tracheostomy in acute traumatic spinal cord injury: a systematic review and meta-analysis. J Trauma Acute Care Surg. 2022;92(1):223-231. doi:10.1097/TA.0000000000003394 Brown CVR, de Moya M, Brasel KJ, et al. Blunt thoracic aortic injury: a Western Trauma Association critical decisions algorithm. J Trauma Acute Care Surg. 2023;94(1):113-116. doi:10.1097/TA.0000000000003759 Agrawal A, Chaddha U, Kaul V, Desai A, Gillaspie E, Maldonado F. Multidisciplinary management of chylothorax. Chest. 2022;162(6):1402-1412. doi:10.1016/j.chest.2022.06.012 Bordeianou L, Paquette I, Johnson E, et al. Clinical practice guidelines for the treatment of rectal prolapse. Dis Colon Rectum. 2017;60(11):1121-1131. doi:10.1097/DCR.0000000000000889 Lu P, McCarty JC, Fields AC, et al. Risk of appendiceal cancer in patients undergoing appendectomy for appendicitis in the era of increasing nonoperative management. J Surg Oncol. 2019;120(3):452-459. Saltiel J, Molinsky R, Lebwohl B. Predictors of outcomes in endoscopies for foreign body ingestion: a cross-sectional study. Dig Dis Sci. 2020;65(9):2637-2643. doi:10.1007/s10620-019-06033-3

  ListenShow Notes
• 

  Episode #65

  2026 Comprehensive General Surgery-Part 1

  Sep 7, 202654 min

  This episode compiles a diverse selection of medical literature focused on clinical management and surgical interventions for various complex health conditions. The collection includes expert guidelines for identifying neurological death in both children and adults, alongside reviews on endocrine disorders such as hyperthyroidism and pheochromocytoma. Several articles analyze oncological challenges, specifically addressing the treatment of liver cancer, retroperitoneal sarcomas, and lifestyle adaptations for breast cancer patients. Additionally, the sources examine gastrointestinal pathologies, offering insights into the complications of pancreatitis, the diagnosis of constipation, and the repair of enterocutaneous fistulas. Collectively, these references provide a comprehensive framework for practitioners to improve patient outcomes through evidence-based surgical and therapeutic strategies. DISCLAIMER The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns. CLINICAL MANAGEMENT AND SURGICAL REVIEW: A COMPREHENSIVE STUDY GUIDE TOP TEN TAKEAWAYS Multidisciplinary Brain Death Standards: Determination of brain death (death by neurologic criteria) is now governed by a 2023 consensus guideline unified across pediatric and adult populations by the AAN, AAP, CNS, and SCCM. Specialized Perioperative Care for Pheochromocytoma: Successful management of pheochromocytoma requires specific attention to the perioperative period to mitigate hemodynamic risks. Vascular Integration in Sarcoma Surgery: Retroperitoneal sarcoma surgery often necessitates complex vascular interventions, including major vascular resections or en-bloc resection with the inferior vena cava (IVC). Long-term Outcomes in Sarcoma: Twenty-year institutional data indicates that en-bloc resection with the IVC is a viable surgical strategy for retroperitoneal sarcoma. Evidence-Based Lifestyle Support in Oncology: For women with or at high risk of breast cancer, systematic reviews and network meta-analyses highlight specific exercise and dietary interventions to optimize body composition. Evolving Management of Hyperthyroidism: Current clinical standards for hyperthyroidism have been synthesized in major 2023 reviews, reflecting updated diagnostic and therapeutic pathways. Surgical Morbidity Considerations: Resection of retroperitoneal sarcomas carries specific surgical morbidity risks that must be weighed during operative planning. Diagnostic Advances in Constipation: Modern management of constipation incorporates recent diagnostic advances, including an assessment of the utility of plain film imaging. Pancreatitis Complications: Management of pancreatic disease involves a dual focus on the acute phase of inflammation and the long-term complications associated with chronic pancreatitis. Hepatocellular Carcinoma (HCC) Standards: Management strategies for HCC continue to be refined, with comprehensive reviews appearing in major surgical literature as of 2023. STUDY GUIDE I. Endocrine Pathology and Perioperative Management The literature emphasizes the complexity of managing endocrine tumors and thyroid dysfunction. Pheochromocytoma management is divided into general clinical overviews and specific perioperative strategies. Key areas of focus include: Pheochromocytoma: Comprehensive reviews detail the pathophysiology and clinical regulation of this tumor. Perioperative Optimization: Specific protocols are required for patients undergoing surgery for pheochromocytoma to manage the catecholamine-related risks associated with the procedure. Hyperthyroidism: Recent reviews in the medical literature provide updated frameworks for diagnosing and treating hyperthyroid states, ensuring clinicians have access to the latest evidence-based practices. II. Surgical Oncology and Complex Resections Surgical management of malignancies, particularly those in the retroperitoneum and liver, requires advanced technical approaches and an understanding of long-term morbidity. Retroperitoneal Sarcoma (RPS): Vascular Involvement: Resection often involves major vascular structures. Data from single-institution studies spanning 20 years support the use of en-bloc resection with the inferior vena cava. Surgical Risks: Literature specifically addresses the morbidity associated with RPS resections, emphasizing the need for specialized surgical expertise. Hepatocellular Carcinoma (HCC): Management reviews provide a current look at the surgical and systemic approaches to liver cancer. Breast Cancer Interventions: Beyond surgical or pharmacological treatment, the role of physical activity and diet is critical. Meta-analyses have identified effective exercise and dietary interventions specifically for improving body composition in women who are either high-risk or already diagnosed with breast cancer. III. Gastrointestinal and Pancreatic Disorders Management of the digestive system covers a spectrum from functional disorders to severe inflammatory conditions and fistulas. Enterocutaneous Fistulas: These complex surgical challenges require specific management approaches to ensure closure and patient stability. Pancreatitis: Acute Phase: Reviews of acute pancreatitis focus on immediate management and the inflammatory response. Chronic Complications: Long-term management involves addressing the various complications that arise from persistent pancreatic inflammation. Constipation: Diagnosis and Treatment: Advances in the field have refined how clinicians approach chronic constipation. Imaging Utility: The specific role of plain film radiography remains a point of clinical evaluation in the diagnostic workup of the "loaded" abdomen. IV. Neurologic Criteria for Death The definition and determination of death have been refined through multi-society cooperation. Consensus Guidelines: In 2023, a major report was released by the American Academy of Neurology (AAN) in subcommittee with the American Academy of Pediatrics (AAP), the Congress of Neurological Surgeons (CNS), and the Society of Critical Care Medicine (SCCM). Unified Standards: These guidelines provide a standardized approach to determining brain death/death by neurologic criteria that applies to both pediatric and adult patients. REFERENCES Farrugia FA, Charalampopoulos A. Pheochromocytoma. Endocr Regul. 2019;53(3):191-212. doi: 10.2478/enr-2019-0020. Naranjo J, Dodd S, Martin YN. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth. 2017;31(4):1427-1439. doi: 10.1053/j.jvca.2017.02.023. Heimroth J, Chen E, Sutton E. Management approaches for enterocutaneous fistulas. Am Surg. 2018;84(3):326-333. Greer DM, Kirschen MP, Lewis A, et al. Pediatric and adult brain death/death by neurologic criteria consensus guideline: report of the AAN guidelines subcommittee, AAP, CNS, and SCCM. Neurology. 2023:10.1212/WNL.0000000000207740. doi: 10.1212/WNL.0000000000207740. Kudiarasu C, Lopez P, Galvão DA, et al. What are the most effective exercise, physical activity and dietary interventions to improve body composition in women diagnosed with or at high-risk of breast cancer? a systematic review and network meta-analysis. Cancer. 2023;129(23):3697-3712. doi: 10.1002/cncr.35043. Lee SY, Pearce EN. Hyperthyroidism: a review. JAMA. 2023;330(15):1472-1483. doi:10.1001/jama.2023.19052. Brown ZJ, Tsilimigras DI, Ruff SM, et al. Management of hepatocellular carcinoma: a review. JAMA Surg. 2023;158(4):410-420. doi:10.1001/jamasurg.2022.7989. Blair AB, Reames BN, Singh J, et al. Resection of retroperitoneal sarcoma en-bloc with inferior vena cava: 20 year outcomes of a single institution. J Surg Oncol. 2018;118(1):127-137. doi:10.1002/jso.25096. Tzanis D, Bouhadiba T, Gaignard E, Bonvalot S. Major vascular resections in retroperitoneal sarcoma. J Surg Oncol. 2018;117(1):42-47. doi:10.1002/jso.24920. MacNeill AJ, Fiore M. Surgical morbidity in retroperitoneal sarcoma resection. J Surg Oncol. 2018;117(1):56-61. doi:10.1002/jso.24902. Ramsey ML, Conwell DL, Hart PA. Complications of chronic pancreatitis. Dig Dis Sci. 2017;62(7):1745-1750. doi: 10.1007/s10620-017-4518-x. Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021;325(4):382-390. doi: 10.1001/jama.2020.20317. Wald A. Constipation: Advances in diagnosis and treatment. JAMA. 2016;315(2):185-191. doi:10.1001/jama.2015.16994. Rangan V. Taking a load off diagnosing constipation: utility of the plain film. Dig Dis Sci. 2019;64(12):3369-3371. doi:10.1007/s10620-019-05878-y.

  ListenShow Notes
• 

  Episode #59

  Lit Review: Advancements in Burn Care and Triage

  Sep 4, 202642 min

  These recent studies explore modern strategies for managing serious burn injuries, ranging from advanced wound closure to systemic triage improvements. One report details a consensus of experts on using laboratory-grown skin grafts for patients with massive tissue loss, offering standardized guidelines for surgical planning and long-term rehabilitation. Another study validates an enzymatic debridement treatment that dissolves damaged tissue chemically, which significantly reduces the need for surgery and limits blood loss compared to traditional methods. Finally, research into a tiered tele-triage system demonstrates how specialized nursing teams can use remote imaging to efficiently categorize referrals. This digital approach optimizes hospital resources by filtering out low-acuity cases and ensuring that critical beds are reserved for the most severe trauma patients. Together, these advancements highlight a shift toward specialized technology and resource-conscious protocols in emergency burn care. DISCLAIMER The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns. ADVANCEMENTS IN BURN CARE: FROM DEBRIDEMENT TO TELE-TRIAGE STUDY GUIDE TOP TEN TAKEAWAYS CEA for Severe Burns: Cultured epithelial autograft (CEA), marketed as Epicel, is a humanitarian device used for wound closure in patients with very large total body surface area (TBSA) thermal injuries, typically ≥30%. Early Biopsy for CEA: Expert consensus recommends that skin biopsies for laboratory-grown keratinocytes should be sent as soon as possible, ideally within 1 to 2 days of admission or the decision to use CEA. Selective Enzymatic Debridement: Anacaulase-bcdb (NexoBrid) is a nonsurgical modality that achieves selective debridement of burn eschar, preserving viable dermis while removing necrotic tissue. Reduced Surgical Burden: The DETECT trial demonstrated that only 4% of patients treated with NexoBrid required surgical excision to achieve complete eschar removal, compared to 72% of patients receiving the standard of care (SOC). Blood Loss Mitigation: Enzymatic debridement significantly reduces blood loss associated with eschar removal, with median losses of 14 mL for NexoBrid versus 800 mL for traditional surgical standard of care. CEA Postoperative Protocols: To optimize graft take, CEA areas should be left open to air for at least 6 hours daily, and dressings should be changed daily down to the "bridal veil" primary dressing. Tiered Tele-Triage Efficiency: Implementing a four-tier tele-triage pathway (Green, Blue, Red, Black) can reduce the number of calls to burn providers by an average of 40 per month. Tele-Triage Reliability: Pathway assignments based on imaging and clinical history by specially trained "transfer nurses" reliably predict final patient disposition in more than 85% of cases. Long-Term Cosmesis: Long-term outcomes for enzymatic debridement are noninferior to surgical standards, as measured by the Modified Vancouver Scar Scale (MVSS) at 12 and 24 months. Resource Optimization: The combination of tele-triage for appropriate transfers and nonsurgical debridement tools is critical for managing the scarcity of specialized burn care resources in the United States. STUDY GUIDE I. Cultured Epithelial Autograft (CEA) Clinical Standards Cultured epithelial autograft, specifically the product Epicel, consists of autologous keratinocytes grown in a laboratory. While it is classified as a humanitarian device because formal efficacy has not been demonstrated through traditional trials, it is recognized as a vital tool for achieving wound closure in patients with massive thermal injuries. A. Patient Selection and Preoperative Planning Indications: CEA is indicated for both adult and pediatric patients with TBSA injuries ≥30%. In practice, it is often reserved for larger injuries due to cost. Biopsy Timing: Consensus dictates that biopsies should be initiated early (within 1–2 days) to begin the laboratory growth process. Dermal Support: Dermal substitutes and wide-mesh split-thickness skin graft (STSG) underlays (using ratios such as 4:1 or 6:1) are uniformly recommended to provide a foundation for the CEA. B. Postoperative Care and Rehabilitation Dressing Management: Daily dressing changes should be performed all at once. The removal of all layers must go down to the level of the "bridal veil" primary dressing. Drying Protocol: Consensus recommends the grafted area be left open to air for a minimum of 6 hours per day. Heat lamps may be utilized to assist in the drying process based on clinical judgment. Backing Removal and Activity: The CEA backing is typically removed 10 to 14 days post-surgery. Physical activity restrictions are generally lifted 10 days after the backing removal. Long-term Follow-up: Introduction of compression garments is recommended at approximately 2 months postoperatively, and CO2 laser therapy may be initiated between 3 and 6 months to manage scarring. II. Enzymatic Debridement with NexoBrid NexoBrid (anacaulase-bcdb) represents a paradigm shift from excisional surgery to selective enzymatic removal of burn eschar. This is particularly relevant in mass casualty incidents where surgical expertise may be limited. A. The DETECT Trial Findings Efficacy: NexoBrid achieved complete (>95%) eschar removal in 93% of cases compared to only 4% in the placebo group. Speed of Debridement: The median time to eschar removal was 1.0 day for NexoBrid, significantly faster than the 3.8 days required for traditional standard of care. Safety and Scarring: The study found no deleterious effects on wound closure times. Scarring outcomes at 12 and 24 months, measured by the Modified Vancouver Scar Scale (MVSS), proved that NexoBrid is noninferior to surgical intervention. B. Clinical Implementation Challenges Pain Management: While trial data superficially addressed pain, anecdotal evidence suggests significant pain and sedation requirements during the procedure. Monitoring: Units utilizing enzymatic debridement must have robust protocols for analgesia and sedation monitoring, which may be challenging for centers with limited resources. III. Tele-Triage and Burn Center Resource Management The United States faces a scarcity of burn care resources, with only approximately 130 burn centers and 300 burn surgeons to treat 500,000 injuries annually. Tele-triage protocols aim to ensure that specialty burn beds (approximately 2,000 nationwide) are reserved for the most severe cases. A. Tiered Pathway Definitions The Harborview Medical Center protocol utilizes "transfer nurses" to categorize patients into four colors based on images and history: Green: Low acuity; outpatient follow-up. These referrals do not require a call to the burn provider. Blue: Low acuity; potential for local care or discharge after consultation. Red: Low acuity, but the referring hospital cannot provide necessary wound care or resuscitation, necessitating transfer. Black: High acuity; severe burns (>5% TBSA, airway compromise, full-thickness, or chemical/electrical mechanisms). B. Systemic Impact Provider Workload: The protocol reduced burn provider call volume by a mean of 40 calls per month by filtering Green pathway patients. Transfer Reduction: The implementation led to a steady decrease in unnecessary transfers, as 74% of all referrals were assigned to lower-acuity (Green/Blue) pathways. Task-Shifting: The success of the program relies on biannual training of nursing teams and the use of standardized video training to ensure reliability. REFERENCES Glat P, Quirk L, Hultman S, et al. Establishing Consensus of Best Practice for CEA Use in Treatment of Severe Burns: A US Burn Provider Delphi Study. J Burn Care Res. 2024;45(5):1287-1293. doi:10.1093/jbcr/irae050 Shoham Y, Rosenberg L, Hickerson W, et al. Early Enzymatic Burn Debridement: Results of the DETECT Multicenter Randomized Controlled Trial. J Burn Care Res. 2024;45(2):297-307. doi:10.1093/jbcr/irad142 Agoubi L, Clark N, Gibbs S, et al. Implementation Evaluation of Tiered Tele-Triage Pathways for Burn Center Consultations and Transfers. J Trauma Acute Care Surg. 2024;96(3):409-417. doi:10.1097/TA.0000000000004202

  ListenShow Notes
• 

  Episode #58

  Spinal Cord Injuries

  Sep 3, 20261 hour

  Traumatic spinal cord injuries are critical events that cause immediate physical damage followed by a dangerous secondary cascade of biological complications. These injuries are primarily categorized as complete or incomplete based on the level of remaining sensory and motor function, often assessed using the standardized ASIA scale. Effective management begins with stabilizing the spine and maintaining blood pressure to prevent further neurological decline. Clinical teams must also distinguish between neurogenic and spinal shock, as these conditions impact the patient's physiological stability and long-term prognosis differently. Beyond emergency surgical or medical interventions, successful recovery relies on preventing secondary complications like infections or pressure ulcers. Ultimately, the integration of acute stabilization and long-term rehabilitation is essential for improving the functional independence and survival of affected individuals. DISCLAIMER The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns. Acute Management and Classification of Traumatic Spinal Cord Injury Study Guide TOP TEN TAKEAWAYS Dual Phases of Injury: Spinal cord injury (SCI) involves an initial traumatic impact (hemorrhage, axonal damage, membrane destruction) followed by a secondary pathophysiologic cascade that can exacerbate the damage. Demographic Risk Profile: Approximately 80% of SCI patients are male, with the highest frequency of injury occurring between the ages of 15 and 25. While the average age is 38, the incidence among those over 65 is increasing. Prognostic Significance of Sacral Sparing: In incomplete injuries, "sacral sparing" (motor function at the rectal sphincter or perianal sensation) is a critical clinical sign indicating a better prognosis for recovery. Central Cord Syndrome Prevalence: This is the most common SCI syndrome, typically characterized by upper extremity weakness that is greater than lower extremity weakness. It often results from cervical hyperextension in patients with underlying stenosis. Standardized Assessment (ASIA): The American Spinal Injury Association (ASIA) examination, specifically the ASIA Impairment Scale (AIS), is the universal tool for grading injuries from A (complete) to E (normal). Neurogenic vs. Spinal Shock: Neurogenic shock is a hemodynamic condition (hypotension, bradycardia) resulting from autonomic disruption (usually T6 or above), while spinal shock refers to the temporary loss of all reflex activity below the level of injury. Pharmacological Contraindications: Succinylcholine must be avoided after 72 hours following an SCI due to the risk of life-threatening hyperkalemia caused by the spread of acetylcholine receptors. Imaging Priorities: Computerized Tomography (CT) is the preferred tool for identifying bony fractures, while Magnetic Resonance Imaging (MRI) is essential for evaluating the spinal cord itself, ligaments, and soft tissue compression. Vascular and Respiratory Risks: High cervical injuries (C3–C5) carry a severe risk of respiratory failure due to impaired diaphragmatic innervation, and cervical fractures are frequently associated with blunt vascular injuries. Subacute Complications: SCI patients require aggressive management to prevent pneumonia, pressure ulcers, and deep venous thrombosis (DVT), with DVT prophylaxis recommended for at least 8 weeks. STUDY GUIDE I. Definitions and Pathophysiology Spinal cord injury (SCI) is defined as a traumatic event resulting in transient or permanent loss of motor, sensory, or autonomic function. The injury process occurs in two distinct stages: Primary Injury: The immediate physical damage caused by the impact, leading to hemorrhages in white and gray matter, axonal damage, and destruction of cellular membranes. Secondary Injury: A pathophysiologic cascade of events following the initial trauma that can cause additional, delayed damage to the spinal cord. II. Epidemiology and Economic Impact Incidence: Approximately 17,000 new cases occur annually in the United States. Common Causes: Motor vehicle accidents (36%–48%) are the leading cause, followed by falls (17%–21%), violence (5%–29%), and sports/recreational activities (17%–21%). Demographics: Young males are disproportionately affected (80% of all cases; 90% of sports-related cases). Economic Burden: The national cost of SCI is estimated at $9.7 billion per year. Mortality: SCI patients are 2 to 5 times more likely to die prematurely, with outcomes negatively impacted by lower socioeconomic status. III. Classification of Spinal Cord Injury Injuries are categorized based on the severity and location of the damage. A. Completeness of Injury Complete SCI: Results in a total loss of motor and sensory function below the level of injury, affecting both sides equally. This can be caused by cord transection, bruising, or loss of blood flow. Incomplete SCI: Occurs when some motor or sensory function remains below the level of injury, indicating partial integrity of the spinal cord. This represents the majority of SCI cases. B. The ASIA Impairment Scale (AIS) The AIS is a standardized grading system (A through E) used to classify the severity of the injury: AIS A: Complete injury; no sensory or motor function is preserved in the sacral segments S4-S5. AIS B: Incomplete sensory; sensory function is preserved below the neurological level, but no motor function is present. AIS C: Incomplete motor; more than half of the key muscle groups below the level of injury have a muscle grade of less than 3 (cannot move against gravity). AIS D: Incomplete motor; at least half of the key muscle groups below the level of injury have a muscle grade of 3 or more (can move against gravity). AIS E: Normal; sensory and motor functions are normal. IV. Incomplete Spinal Cord Injury Syndromes Central Cord Syndrome: Most common. Presents with weakness in upper extremities greater than lower extremities. Often caused by cervical hyperextension in patients with stenosis. Brown-Séquard Syndrome: Caused by hemisection (lateral injury) of the cord. Results in ipsilateral (same side) loss of motor function and proprioception, and contralateral (opposite side) loss of pain and temperature sensation. Anterior Cord Syndrome: Caused by flexion injuries or compromise of the anterior spinal artery. Results in loss of motor function, pain, and temperature sensation, but preserves touch and proprioception. Posterior Cord Syndrome: Extremely rare. Involves loss of vibration and proprioception, while motor function and pain/temperature sensation remain intact. Conus Medullaris and Cauda Equina Syndromes: Result from injury to the lower end of the spinal cord or lumbosacral nerve roots. Symptoms include lower extremity weakness and bowel/bladder dysfunction. V. Clinical Assessment and Emergency Management A. Initial Evaluation (ATLS) Management begins with the Airway, Breathing, and Circulation (ABC) protocol. All trauma victims must be assumed to have an unstable spine until proven otherwise. B. Spinal Motion Restriction (SMR) The term "spinal motion restriction" is preferred over "immobilization." Backboards are used for extrication and rapid movement but are not recommended for long-term transport due to skin and comfort concerns. Logroll maneuvers must be used when moving patients to maintain spinal alignment. C. Airway Management High cervical injuries (C3–C5) require early ventilator support. Fiberoptic bronchoscopy may be used during intubation to minimize spinal manipulation. Pharmacology Warning: Succinylcholine is safe immediately after injury but is contraindicated after 72 hours (and up to 6 months) due to the risk of hyperkalemia from acetylcholine receptor upregulation. VI. Neurogenic Shock vs. Spinal Shock It is vital to differentiate between these two conditions: Neurogenic Shock: A distributive shock seen in injuries at or above T6. Characterized by hypotension, bradycardia, and hypothermia due to the loss of sympathetic tone and unopposed vagal tone. Treatment includes fluid resuscitation and vasopressors (norepinephrine, phenylephrine, or dopamine). Spinal Shock: A clinical state of flaccid areflexia (loss of reflexes) below the level of injury. It complicates the initial prognosis because the true extent of the injury (complete vs. incomplete) cannot be determined until spinal shock resolves. The bulbocavernosus reflex is used to test for the presence or resolution of spinal shock. VII. Diagnostic Imaging and Specialized Care CT Scan: The primary screening tool for identifying bony fractures and abnormalities. MRI: Indicated for patients with neurological deficits that are not explained by CT, or to evaluate soft tissue, cord compression (blood clots, herniated discs), and ligamentous injury. Angiography: Recommended for patients with cervical fractures to screen for associated vascular injuries. VIII. Medical and Surgical Management Neuroprotection: High-dose methylprednisolone is controversial and generally not recommended due to side effects (infection, pneumonia) and lack of definitive functional benefit. Surgery: Early decompression (closed or open reduction) is often recommended, especially for bilateral facet dislocations or if the injury is progressing. VTE Prophylaxis: Mechanical devices should be used immediately. Chemical prophylaxis (e.g., heparin/Lovenox) should begin as soon as it is safe and continue for at least 8 weeks. Gastrointestinal Care: Patients are at high risk for ileus and colonic pseudo-obstruction; an aggressive bowel regimen and anorectal stimulation are required early. Skin Care: Meticulous monitoring is necessary to prevent pressure ulcers, which are difficult to heal once they form. IX. Long-Term Prognosis Prognosis is determined by the severity of the injury, age, and complications. The ASIA exam should be performed within 72 hours to predict recovery. Even in AIS A (complete) injuries, 20% of patients show some improvement. Approximately 75% of AIS C patients eventually recover some walking function. REFERENCES Wilson JL, Nunn AM, Couture DE. Acute Management and Classification of Traumatic Spinal Cord Injury. In: Acute Management and Classification of Traumatic Spinal Cord Injury.

  ListenShow Notes
• 

  Episode #57

  ECMO Principles

  Sep 2, 202649 min

  This episode explores the clinical application of Extracorporeal Membrane Oxygenation (ECMO), a specialized technology used to support patients facing life-threatening heart or lung failure. It details the two primary configurations, venovenous (VV) for respiratory support and venoarterial (VA) for circulatory assistance, while tracing the historical evolution of the field from early failures to modern success. A significant focus is placed on the necessity of a multidisciplinary medical team and the rigorous criteria required for proper patient selection and cannulation. The authors also address the technical complexities of the ECMO circuit, the management of common complications like bleeding, and the protocols for weaning patients off support. Ultimately, the source highlights that while ECMO is a resource-intensive therapy with persistent controversies, it serves as a vital physiological bridge that allows failing organs the time needed to recover. DISCLAIMER The Critical Edge is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor does it substitute for professional medical advice, diagnosis, or treatment from a qualified healthcare provider—always seek in-person evaluation and care from your physician or trauma team for any health concerns. EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) STUDY GUIDE TOP TEN TAKEAWAYS Dual Functional Purpose: ECMO (also known as Extracorporeal Life Support or ECLS) serves to replace the oxygenation and ventilation functions of the lungs and, depending on its configuration, the perfusion functions of the heart during acute organ injury. Configuration Distinction: Venovenous (VV-ECMO) is primarily utilized for acute lung injury when cardiac function is adequate, while Venoarterial (VA-ECMO) provides both respiratory and circulatory support for patients with significant cardiac impairment. Historical Evolution: After catastrophic initial trials in the 1970s, ECMO became a viable therapy through the leadership of Dr. Robert Bartlett and the establishment of the Extracorporeal Life Support Organization (ELSO) in the late 1980s. Multidisciplinary Expertise: Successful programs require a highly integrated team including cardiothoracic surgeons, perfusionists, ECMO specialists (RNs or respiratory therapists), and physician champions from various subspecialties like nephrology and neurology. Predictive Scoring: Clinical tools such as the Respiratory ECMO Survival Prediction (RESP) score and the Survival After Veno-Arterial ECMO (SAVE) score help identify optimal candidates and risk-stratify outcomes. Cannulation Safety: Vascular access typically involves large-bore cannulas placed percutaneously via the Seldinger technique. For femoral VA-ECMO, the placement of a distal perfusion catheter is critical to prevent limb ischemia and potential amputation. The ECMO Circuit: The closed-loop system uses a centrifugal pump and a microporous hollow fiber oxygenator. Gas exchange is regulated by "sweep gas" to manage carbon dioxide removal and oxygenation concentration. Management Priorities: The fundamental goal of ECMO is to provide "organ rest," allowing the heart and lungs to recover by minimizing ventilator-induced barotrauma and providing systemic hemodynamic stability. Anticoagulation Necessity: Continuous systemic anticoagulation (typically heparin) is required to prevent circuit thrombosis, though this creates a constant risk-balance challenge regarding clinical bleeding. E-CPR Potential: ECMO-assisted cardiopulmonary resuscitation (E-CPR) is an emerging application that can significantly improve survival and neurologic outcomes for witnessed cardiopulmonary arrests compared to conventional CPR. STUDY GUIDE I. Core Mechanics and Physiology Extracorporeal membrane oxygenation operates by draining deoxygenated venous blood from the body, pumping it through an artificial membrane for gas exchange, and returning it to the patient. VV-ECMO: Blood is drained from the venous system and returned near the right atrium. It requires a functioning heart to pump the newly oxygenated blood through the pulmonary and systemic vascular systems. VA-ECMO: Blood is returned to the arterial system (typically the aorta), bypassing both the heart and lungs. This configuration supports critical end-organ metabolic needs when native cardiac output is insufficient. II. Historical Context and Organizations The history of ECMO is marked by early failure followed by technological and protocol refinement. 1970s NIH Trials: Early results were poor, with survival rates below 10%, leading to temporary abandonment of the therapy. These failures were attributed to technological deficiencies and lack of management guidelines. The Michigan Influence: Dr. Robert Bartlett’s work in the 1980s and 1990s at the University of Michigan established the foundation for modern ECLS. ELSO: The Extracorporeal Life Support Organization maintains an international registry and provides the standards, guidelines, and protocols used by centers of excellence worldwide. III. Clinical Indicators and Patient Selection ECMO is a supportive tool, not a primary treatment. It stabilizes the patient while underlying causes (e.g., pneumonia, myocardial infarction) are treated. Respiratory Criteria: Indicated when the risk of mortality from respiratory failure exceeds 80%. This is often measured by the Murray Score, which evaluates four variables: Pao2/Fio2 ratio, Positive End-Expiratory Pressure (PEEP), chest x-ray quadrants with infiltrates, and pulmonary compliance. Cardiac Criteria: Indicated for cardiogenic shock, such as postcardiotomy shock or acute myocardial infarction, where maximal medical therapies and other mechanical supports (like intra-aortic balloon pumps) have failed. Contraindications: Absolute: Terminal malignancies, acute anoxic brain injury, or comorbidities precluding meaningful survival. Relative: Mechanical ventilation for more than seven days on high settings, advanced age, extreme obesity, or severe chronic medical immunosuppression. IV. Cannulation and Technical Execution Cannulation is a high-risk technical task requiring proficiency in wire handling and vascular management. Access Sites: Common sites include the femoral vein, right internal jugular vein, and femoral artery. Central cannulation (directly into the right atrium or aorta) may be used following cardiac surgery. The Distal Perfusion Catheter: In femoral VA-ECMO, a large cannula can occlude the femoral artery. A 6- to 8-French introducer must be placed retrograde to the superficial femoral artery to ensure the lower limb receives adequate blood flow. Recirculation: In VV-ECMO, if the drainage and inflow cannulas are too close, oxygenated blood may be immediately drained back into the circuit, reducing the efficiency of systemic oxygenation. Dual Lumen Cannulas: Advanced cannulas (e.g., Avalon or Crescent) allow for single-site access (usually the right internal jugular), promoting patient mobility and potential extubation, though they require precise positioning via echocardiography. V. Maintenance and Circuit Management Anticoagulation: Patients must be heparinized before cannulation (Target Activated Clotting Time > 250 seconds). Maintenance PTT levels typically range from 40 to 80 seconds. The "Sweep": Gas flow through the oxygenator. Increasing the sweep gas increases the removal of carbon dioxide. Ventilator Strategy: The "lung rest" strategy involves minimal Fio2 and low pressure settings to avoid further barotrauma while the patient is on the circuit. Sedation: ECMO patients often require higher doses of fentanyl and benzodiazepines than standard ICU patients, though the physiological reason for this remains poorly understood. VI. Complications and Troubleshooting Bleeding: The most common complication due to continuous anticoagulation. Thrombocytopenia: Often occurs due to platelet activation and mechanical trauma within the circuit. Neurologic Injury: Intracranial bleeding is a significant risk due to the combination of high-level anticoagulation and potential pre-ECMO hypoxia. Acute Kidney Injury: Common following the initial ischemic insult; renal replacement therapy can often be integrated directly into the ECMO circuit. VII. Weaning and Decannulation VV-ECMO Weaning: Performed by slowly decreasing the "sweep" gas. When the sweep is off and the patient maintains adequate gas exchange via the lungs alone, they are ready for decannulation. VA-ECMO Weaning: A more complex process requiring echocardiography and hemodynamic monitoring. Pump flow is gradually reduced to allow the heart to take over the workload while monitoring for signs of ventricular failure or high filling pressures. Decannulation: Venous cannulas can often be removed at the bedside with purse-string sutures and pressure. Arterial cannulas typically require surgical repair in the operating room. VIII. Glossary of Key Terminology AOI (Oxygenation Index): A calculation used to assess the severity of lung injury; higher values indicate more severe impairment. E-CPR (ECMO-assisted Cardiopulmonary Resuscitation): The application of VA-ECMO during active cardiac arrest to facilitate stabilization and diagnosis. Inflow: The "arterialized" or oxygenated blood being returned to the patient. PAPI (Pulmonary Artery Pulsatility Index): A marker for right ventricular function used during weaning from VA-ECMO. Recirculation: A phenomenon in VV-ECMO where oxygenated blood is pulled back into the drainage cannula before reaching the systemic circulation. Seldinger Technique: A medical procedure to obtain safe access to blood vessels or other hollow organs using a guide wire. Sweep Gas: The flow of gas (oxygen/air) across the oxygenator membrane used to clear carbon dioxide from the blood. REFERENCES Firstenberg MS, Libby M, Abelson J. Extracorporeal membrane oxygenation for acute cardiopulmonary failure. In: Firstenberg MS, ed. Pasted Text. [City, State of publication unknown]: [Publisher unknown]; [Year unknown]:1-25. Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis. 1988;138:720–723. Bartlett RH. Extracorporeal life support: the University of Michigan experience. JAMA. 2000;283(7):904-908. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374(9698):1351-1363. Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378(20):1905-1915. Chen YS, Lin JW, Yu HY, et al. Cardio-pulmonary resuscitation with assisted extracorporeal life-support versus conventional cardio-pulmonary resuscitation in adults with in-hospital cardiac arrest: an observational study and propensity analysis. Lancet. 2008;372(9638):554-561. Yannopoulos D, Bartos J, Raveendran G, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396(10265):1807-1816. Papadimos TJ, Henn MC, Baudendistel TE, et al. Ethics of extracorporeal membrane oxygenation: five dilemmas. Chest. 2014;145(5):1157-1164.

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.